15
Views
9
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Effect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia

, &
Pages 48-55 | Published online: 28 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Regine Sitruk-Ware, Ronald Bossemeyer & Phillipe Bouchard. (2007) Preclinical and clinical properties of trimegestone: A potent and selective progestin. Gynecological Endocrinology 23:6, pages 310-319.
Read now
P. Bouchard, F. De Cicco-Nardone, D. Spielmann, N. Garcea & The Trimegestone 301 Study Group. (2005) Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women. Gynecological Endocrinology 21:3, pages 142-148.
Read now

Articles from other publishers (7)

Shanshan QI. (2017) Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats. Biological Trace Element Research 183:2, pages 288-295.
Crossref
Ruchun Dai, Yulin Ma, Zhifeng Sheng, Yan Jin, Yuhai Zhang, Lingna Fang, Huijie Fan & Eryuan Liao. (2008) Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats. Journal of Bone and Mineral Metabolism 26:4, pages 342-349.
Crossref
Regine Sitruk-Ware. (2006) New progestagens for contraceptive use. Human Reproduction Update 12:2, pages 169-178.
Crossref
R??gine Sitruk-Ware. (2004) New Progestogens. Drugs & Aging 21:13, pages 865-883.
Crossref
Jos H.H Thijssen. (2003) Overview on the effects of progestins on bone. Maturitas 46, pages 77-87.
Crossref
Richard C Winneker, Daniel Bitran & Zhiming Zhang. (2003) The preclinical biology of a new potent and selective progestin: trimegestone. Steroids 68:10-13, pages 915-920.
Crossref
Patrick Bernardelli, Bernard Gaudillière & Fabrice Vergne. 2002. Annual Reports in Medicinal Chemistry Volume 37. Annual Reports in Medicinal Chemistry Volume 37 257 277 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.